Works matching Delta-9-tetrahydrocannabinol

Results: 621

Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report.

Published in:

International Journal of Psychiatry in Medicine, 2019, v. 54, n. 2, p. 150, doi. 10.1177/0091217418791455

By:

Pichler, Eva-Maria;
Kawohl, Wolfram;
Seifritz, Erich;
Roser, Patrik

Publication type:

Article

KANABIDIOL (CBD) IN DELTA-9-TETRAHIDROKANABINOL (THC) V NAVADNI KONOPLJI (Cannabis sativa L.).

Published in:

Hmeljarski Bilten, 2018, n. 25, p. 59

By:

ZAGOŽEN, Marjeta;
KREFT, Samo;
ČERENAK, Andreja

Publication type:

Article

Effect of Lipid Vehicles on Solubility, Stability, and Topical Permeation of Delta-9-Tetrahydrocannabinol.

Published in:

AAPS PharmSciTech, 2022, v. 23, n. 6, p. 1, doi. 10.1208/s12249-022-02385-8

By:

Shankar, Vijay Kumar;
Shettar, Abhishek;
Rangappa, Srinath;
Ellis, Inayet;
Dave, Masumi;
Murthy, Reena;
Murthy, S. Narasimha

Publication type:

Article

Role of the Hypothalamic-Pituitary Adrenal Axis in the Suppression of Luteinizing Hormone Release by Delta-9-Tetrahydrocannabinol.

Published in:

Neuroendocrinology, 1997, v. 65, n. 6, p. 446, doi. 10.1159/000127208

By:

Jackson, April L.;
Murphy, Laura L.

Publication type:

Article

Effects of Delta-9-Tetrahydrocannabinol on the Hypothalamic-Pituitary Control of Luteinizing Hormone and Follicle-Stimulating Hormone Secretion in Adult Male Rats.

Published in:

Neuroendocrinology, 1987, v. 46, n. 6, p. 488, doi. 10.1159/000124870

By:

Wenger, T.;
Rettori, V.;
Snyder, G.D.;
Dalterio, S.;
McCann, S.M.

Publication type:

Article

Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta‐9‐Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple Routes.

Published in:

CTS: Clinical & Translational Science, 2025, v. 18, n. 1, p. 1, doi. 10.1111/cts.70119

By:

Qian, Lixuan;
Zhang, Tao;
Dinh, Jean;
Paine, Mary F.;
Zhou, Zhu

Publication type:

Article

Delta-9-Tetrahydrocannabinol (∆-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats.

Published in:

Neurotoxicity Research, 2018, v. 33, n. 2, p. 402, doi. 10.1007/s12640-017-9806-x

By:

Suliman, Noor Azuin;
Taib, Che Norma Mat;
Moklas, Mohamad Aris Mohd;
Basir, Rusliza

Publication type:

Article

Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans.

Published in:

Brain Sciences (2076-3425), 2019, v. 9, n. 4, p. 93, doi. 10.3390/brainsci9040093

By:

Colizzi, Marco;
Weltens, Nathalie;
McGuire, Philip;
Van Oudenhove, Lukas;
Bhattacharyya, Sagnik

Publication type:

Article

Prenatal Exposure to Delta-9-tetrahydrocannabinol (THC) Alters the Expression of miR-122-5p and Its Target Igf1r in the Adult Rat Ovary.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 14, p. 8000, doi. 10.3390/ijms23148000

By:

Martínez-Peña, Annia A.;
Lee, Kendrick;
Pereira, Madison;
Ayyash, Ahmed;
Petrik, James J.;
Hardy, Daniel B.;
Holloway, Alison C.

Publication type:

Article

Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 5, p. 2757, doi. 10.3390/ijms23052757

By:

Wang, Yanhong;
Hong, Yuzhu;
Yan, Jiyu;
Brown, Breanna;
Lin, Xiaoyang;
Zhang, Xiaolin;
Shen, Ning;
Li, Minghua;
Cai, Jianfeng;
Gordon, Marcia;
Morgan, David;
Zhou, Qingyu;
Cao, Chuanhai

Publication type:

Article

Elucidating the acute effects of medically prescribed oral and vaporised delta‐9‐tetrahydrocannabinol on cognitive functions important for driving.

Published in:

Drug & Alcohol Review, 2025, v. 44, n. 4, p. 1010, doi. 10.1111/dar.14060

By:

Stefanidis, Kayla B.;
Schiemer, Carla;
Mieran, Taren;
Hill, Andrew;
Horswill, Mark S.;
Summers, Mathew J.

Publication type:

Article

Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study.

Published in:

Neuropsychopharmacology, 2011, v. 36, n. 7, p. 1340, doi. 10.1038/npp.2011.17

By:

Winton-Brown, Toby T.;
Allen, Paul;
Bhattacharrya, Sagnik;
Borgwardt, Stefan J.;
Fusar-Poli, Paolo;
Crippa, Jose A.;
Seal, Marc L.;
Martin-Santos, Rocio;
Ffytche, Dominic;
Zuardi, Antonio W.;
Atakan, Zerrin;
McGuire, Philip K

Publication type:

Article

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 8, p. 1558, doi. 10.1038/sj.npp.1300496

By:

D'Souza, Deepak Cyril;
Perry, Edward;
MacDougall, Lisa;
Ammerman, Yola;
Cooper, Thomas;
Yu-te Wu;
Braley, Gabriel;
Gueorguieva, Ralitza;
Krystal, John Harrison

Publication type:

Article

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.

Published in:

Psychopharmacology, 2022, v. 239, n. 11, p. 3731, doi. 10.1007/s00213-022-06248-9

By:

Hutten, Nadia R. P. W.;
Arkell, T. R.;
Vinckenbosch, F.;
Schepers, J.;
Kevin, R. C.;
Theunissen, E. L.;
Kuypers, K. P. C.;
McGregor, I. S.;
Ramaekers, J. G.

Publication type:

Article

Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women.

Published in:

Psychopharmacology, 2022, v. 239, n. 5, p. 1487, doi. 10.1007/s00213-021-06032-1

By:

Wardle, Margaret C.;
Pabon, Elisa;
Webber, Heather E.;
de Wit, Harriet

Publication type:

Article

In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers.

Published in:

Psychopharmacology, 2020, v. 237, n. 10, p. 3097, doi. 10.1007/s00213-020-05595-9

By:

Schindler, Emmanuelle A. D.;
Schnakenberg Martin, Ashley M.;
Sewell, R. Andrew;
Ranganathan, Mohini;
DeForest, Anna;
Pittman, Brian P.;
Perrino, Albert;
D'Souza, Deepak C.

Publication type:

Article

Prenatal delta-9-tetrahydrocannabinol exposure is associated with changes in rhesus macaque DNA methylation enriched for autism genes.

Published in:

Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01519-4

By:

Shorey-Kendrick, Lyndsey E.;
Roberts, Victoria H. J.;
D'Mello, Rahul J.;
Sullivan, Elinor L.;
Murphy, Susan K.;
Mccarty, Owen J. T.;
Schust, Danny J.;
Hedges, Jason C.;
Mitchell, A. J.;
Terrobias, Jose Juanito D.;
Easley IV, Charles A.;
Spindel, Eliot R.;
Lo, Jamie O.

Publication type:

Article

Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 1, p. 77, doi. 10.1002/hup.1166

By:

Morrison, P. D.;
Stone, J. M.

Publication type:

Article

Molecular Docking Studies of HIV-1 Protease-, Integrase- and Reverse-Transcriptase with Delta-9-tetrahydrocannabinol and Curcumin as Two Herbal Ligands.

Published in:

Journal of Evolutionary Biochemistry & Physiology, 2021, v. 57, n. 2, p. 281, doi. 10.1134/S0022093021020101

By:

Esmaeili, S.;
Mosaddeghi, H.;
Ravari, F.

Publication type:

Article

Prenatal delta-9-tetrahydrocannabinol exposure alters fetal neurodevelopment in rhesus macaques.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-56386-7

By:

Ryan, Kimberly S.;
Karpf, Joshua A.;
Chan, Chi Ngai;
Hagen, Olivia L.;
McFarland, Trevor J.;
Urian, J. Wes;
Wang, Xiaojie;
Boniface, Emily R.;
Hakar, Melanie H.;
Terrobias, Jose Juanito D.;
Graham, Jason A.;
Passmore, Scarlet;
Grant, Kathleen A.;
Sullivan, Elinor L.;
Grafe, Marjorie R.;
Saugstad, Julie A.;
Kroenke, Christopher D.;
Lo, Jamie O.

Publication type:

Article

The Effect of Intravenous Administration of Delta-9-Tetrahydrocannabinol on the Activity of A10 Dopamine Neurons Recorded in vivo in Anesthetized Rats.

Published in:

Neuropsychobiology, 1997, v. 36, n. 2, p. 96, doi. 10.1159/000119369

By:

Gifford, Andrew N.;
Gardner, Eliot L.;
Ashby, Jr., Charles R.

Publication type:

Article

Assessment of Delta-9-Tetrahydrocannabinol (THC) in Saliva and Blood After Oral Administration of Medical Cannabis With Respect to its Effect on Driving Abilities.

Published in:

Physiological Research, 2022, v. 71, n. 5, p. 703, doi. 10.33549/physiolres.934907

By:

TROJAN, Vaclav;
LANDA, Leos;
HRIB, Radovan;
JURICA, Jan;
RYCHLICKOVA, Jitka;
ZVONICEK, Vaclav;
HALAMKOVA, Lenka;
HALAMEK, Jan;
DEMLOVA, Regina;
BELASKOVA, Silvie;
SLIVA, Jiri

Publication type:

Article

Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: analgesic efficacy, pharmacokinetics and tolerability.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 81, n. 3, p. 525, doi. 10.1111/bcp.12811

By:

Vries, Marjan;
Van Rijckevorsel, Dagmar C. M.;
Vissers, Kris C. P.;
Wilder‐Smith, Oliver H. G.;
Van Goor, Harry

Publication type:

Article

Effects of Delta-9-Tetrahydrocannabinol, Cannabinol and Cannabidiol, Alone and in Combinations, on Luteinizing Hormone and Prolactin Release and on Hypothalamic Neurotransmitters in the Male Rat.

Published in:

Neuroendocrinology, 1990, v. 52, n. 4, p. 316, doi. 10.1159/000125604

By:

Murphy, Laura L.;
Steger, Richard W.;
Smith, Susan;
Bartke, Andrzej

Publication type:

Article

Disposable screen printed sensor for the electrochemical detection of delta-9-tetrahydrocannabinol in undiluted saliva.

Published in:

Chemistry Central Journal, 2016, v. 10, n. 1, p. 1, doi. 10.1186/s13065-016-0148-1

By:

Wanklyn, Ceri;
Burton, Dan;
Enston, Emma;
Bartlett, Carrie-Ann;
Taylor, Sarah;
Raniczkowska, Aleksandra;
Black, Murdo;
Murphy, Lindy

Publication type:

Article

Adolescent Exposure to Chronic Delta-9-Tetrahydrocannabinol Blocks Opiate Dependence in Maternally Deprived Rats.

Published in:

Neuropsychopharmacology, 2009, v. 34, n. 11, p. 2469, doi. 10.1038/npp.2009.70

By:

Morel, Lydie J.;
Giros, Bruno;
Daugé, Valérie

Publication type:

Article

Quantifying Heart Rate Changes After Delta-9-Tetrahydrocannabinol Administration Using a PBPK-PD Model in Healthy Adults.

Published in:

Pharmaceutics, 2025, v. 17, n. 2, p. 237, doi. 10.3390/pharmaceutics17020237

By:

Qian, Lixuan;
Zhou, Zhu

Publication type:

Article

Acute effects of oral delta‐9‐tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects.

Published in:

Psychophysiology, 2022, v. 59, n. 2, p. 1, doi. 10.1111/psyp.13955

By:

Pabon, Elisa;
Rockwood, Frederica;
Norman, Greg J.;
de Wit, Harriet

Publication type:

Article

Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study.

Published in:

PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0220025

By:

Chung, Hery;
Fierro, Angélica;
Pessoa-Mahana, C. David

Publication type:

Article

Effects of cannabidiol without delta-9-tetrahydrocannabinol on canine atopic dermatitis: A retrospective assessment of 8 cases.

Published in:

Canadian Veterinary Journal / Revue Vétérinaire Canadienne, 2022, v. 63, n. 4, p. 423

By:

Chie Mogi;
Masanori Yoshida;
Koji Kawano;
Takaaki Fukuyama;
Toshiro Arai

Publication type:

Article

Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis.

Published in:

Addiction, 2021, v. 116, n. 5, p. 1000, doi. 10.1111/add.15253

By:

Freeman, Tom P.;
Craft, Sam;
Wilson, Jack;
Stylianou, Stephan;
ElSohly, Mahmoud;
Di Forti, Marta;
Lynskey, Michael T.

Publication type:

Article

Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies.

Published in:

Journal of Central Nervous System Disease, 2019, v. 11, p. N.PAG, doi. 10.1177/1179573519831997

By:

Akgün, Katja;
Essner, Ute;
Seydel, Cordula;
Ziemssen, Tjalf

Publication type:

Article

Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies.

Published in:

Journal of Central Nervous System Disease, 2019, v. 11, p. N.PAG, doi. 10.1177/1179573519831997

By:

Akgün, Katja;
Essner, Ute;
Seydel, Cordula;
Ziemssen, Tjalf

Publication type:

Article

The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ<sup>9</sup>-THC) in humans.

Published in:

2018

By:

Boggs, Douglas L.;
Cortes-Briones, Jose A.;
Surti, Toral;
Luddy, Christina;
Ranganathan, Mohini;
Cahill, John D.;
Sewell, Andrew R.;
D’Souza, Deepak C.;
Skosnik, Patrick D.;
D'Souza, Deepak C

Publication type:

journal article

Quantity of delta‐9‐tetrahydrocannabinol consumption and cannabis use disorder among daily cannabis consumers.

Published in:

Addiction, 2025, v. 120, n. 4, p. 676, doi. 10.1111/add.16700

By:

Borodovsky, Jacob T.;
Hasin, Deborah S.;
Wall, Melanie;
Struble, Cara A.;
Habib, Mohammad I.;
Livne, Ofir;
Liu, Jun;
Chen, Lynn;
Aharonovich, Efrat;
Budney, Alan J.

Publication type:

Article

Lack of Cardiovascular Effects of Delta-9-Tetrahydrocannabinol in Chemically Denervated Men.

Published in:

Annals of Internal Medicine, 1979, v. 91, n. 4, p. 571, doi. 10.7326/0003-4819-91-4-571

By:

Kanakis, Charles;
Pouget, J. Maurice;
Rosen, Kenneth M.

Publication type:

Article

A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.

Published in:

1981

By:

Chang, A E;
Shiling, D J;
Stillman, R C;
Goldberg, N H;
Seipp, C A;
Barofsky, I;
Rosenberg, S A

Publication type:

journal article

Development and validation of a quantitative method for the analysis of delta‐9‐tetrahydrocannabinol (delta‐9‐THC), delta‐8‐tetrahydrocannabinol (delta‐8‐THC), delta‐9‐tetrahydrocannabinolic acid (THCA), and cannabidiol (CBD) in botanicals, edibles, liquids, oils, waxes, and bath products by gas chromatography mass spectrometry (GC/MS)

Published in:

Journal of Forensic Sciences, 2024, v. 69, n. 5, p. 1718, doi. 10.1111/1556-4029.15574

By:

Shuda, Sarah A.;
Folger, Joshua F.;
Spargo, Erin;
Logan, Barry K.

Publication type:

Article

Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats.

Published in:

Addiction Biology, 2007, v. 12, n. 3/4, p. 485, doi. 10.1111/j.1369-1600.2007.00074.x

By:

Campolongo, Patrizia;
Trezza, Viviana;
Cassano, Tommaso;
Gaetani, Silvana;
Morgese, Maria Grazia;
Ubaldi, Massimo;
Soverchia, Laura;
Antonelli, Tiziana;
Ferraro, Luca;
Massi, Maurizio;
Ciccocioppo, Roberto;
Cuomo, Vincenzo

Publication type:

Article

Actions of delta-9-tetrahydrocannabinol in cannabis: Relation to use, abuse, dependence.

Published in:

International Review of Psychiatry, 2009, v. 21, n. 2, p. 104, doi. 10.1080/09540260902782752

By:

Cooper, Ziva D.;
Haney, Margaret

Publication type:

Article

Oxidative Stress Status in Testis of Type-2 Diabetic Rats Treated with Delta-9-Tetrahydrocannabinol.

Published in:

European Journal of Biology, 2021, v. 80, n. 2, p. 91, doi. 10.26650/EurJBiol.2021.1001540

By:

Tutar, Ebrar;
Pesen, Beti;
Coskun Yazici, Zeynep Mine;
Bolkent, Sema

Publication type:

Article

Pharmacokinetics and central accumulation of delta-9-tetrahydrocannabinol (THC) and its bioactive metabolites are influenced by route of administration and sex in rats.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03242-7

By:

Baglot, Samantha L.;
Hume, Catherine;
Petrie, Gavin N.;
Aukema, Robert J.;
Lightfoot, Savannah H. M.;
Grace, Laine M.;
Zhou, Ruokun;
Parker, Linda;
Rho, Jong M.;
Borgland, Stephanie L.;
McLaughlin, Ryan J.;
Brechenmacher, Laurent;
Hill, Matthew N.

Publication type:

Article

Enzymatic Digestion and Selective Quantification of Underivatised Delta-9-Tetrahydrocannabinol and Cocaine in Human Hair Using Gas Chromatography-Mass Spectrometry.

Published in:

Journal of Analytical Methods in Chemistry, 2012, p. 1, doi. 10.1155/2012/907893

By:

Breidi, Salah Eddine;
Barker, James;
Petróczi, Andrea;
Naughton, Declan P.

Publication type:

Article

Hypothalamic Action of Delta-9-Tetrahydrocannabinol to Inhibit the Release of Prolactin and Growth Hormone in the Rat.

Published in:

Neuroendocrinology, 1988, v. 47, n. 6, p. 498, doi. 10.1159/000124961

By:

Rettori, Valeria;
Wenger, Tibor;
Snyder, Gary;
Dalterio, Susan;
McCann, Samuel M.

Publication type:

Article

Reversal of the Delta-9-Tetrahydrocannabinol Inhibitory Effect on Prolactin Secretion by Rostral Deafferentation of the Medial Basal Hypothalamus.

Published in:

Neuroendocrinology, 1986, v. 44, n. 2, p. 204, doi. 10.1159/000124646

By:

Tyrey, Lee

Publication type:

Article

Self-report methodology for quantifying standardized cannabis consumption in milligrams delta-9-tetrahydrocannabinol.

Published in:

American Journal of Drug & Alcohol Abuse, 2023, v. 49, n. 6, p. 723, doi. 10.1080/00952990.2023.2232525

By:

Larsen, Sarah F.;
Johnson, Allegra J.;
Larimer, Mary E.;
Dager, Stephen R.;
Kleinhans, Natalia M.

Publication type:

Article

Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial

Published in:

Addiction, 2012, v. 107, n. 6, p. 1123, doi. 10.1111/j.1360-0443.2011.03757.x

By:

Hjorthøj, Carsten Rygaard;
Fohlmann, Allan;
Larsen, Anne‐Mette;
Arendt, Mikkel;
Nordentoft, Merete

Publication type:

Article

Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol.

Published in:

Psychological Medicine, 2022, v. 52, n. 11, p. 2024, doi. 10.1017/S0033291720003827

By:

Colizzi, Marco;
Weltens, Nathalie;
Lythgoe, David J;
Williams, Steve CR;
Van Oudenhove, Lukas;
Bhattacharyya, Sagnik

Publication type:

Article

Hippocampal differential expression underlying the neuroprotective effect of delta-9-tetrahydrocannabinol microdose on old mice.

Published in:

Frontiers in Neuroscience, 2023, p. 1, doi. 10.3389/fnins.2023.1182932

By:

Shapira, Guy;
Israel-Elgali, Ifat;
Grad, Meitar;
Avnat, Eden;
Rachmany, Lital;
Sarne, Yosef;
Shomron, Noam

Publication type:

Article

Efficacy of Crude Marijuana and Synthetic Delta-9-Tetrahydrocannabinol as Treatment for Chemotherapy-Induced Nausea and Vomiting: A Systematic Literature Review.

Published in:

Oncology Nursing Forum, 2009, v. 36, n. 3, p. 345, doi. 10.1188/09.ONF.345-352

By:

Cotter, Jayme

Publication type:

Article